Björn Rüter
- Hematology top 0.5%
- Molecular Biology
- Genetics top 5%
- Public Health, Environmental and Occupational Health top 10%
- Oncology
- Co-authors
- Michael LübbertPierre W. WijermansRainer ClausArnold GanserUwe PlatzbeckerP. WijermansUlrich GermingAnne Hagemeijer
- Topics
- Acute Myeloid Leukemia Research (24 papers)Epigenetics and DNA Methylation (5 papers)Hematopoietic Stem Cell Transplantation (5 papers)
- Cited by
- HematologyGeneticsEmergency Medicine
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Björn Rüter
29 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 56
- Hematology 1.2k
- Molecular Biology 647
- Genetics 342
- Public Health, Environmental and Occupational Health 245
- Oncology 163
Countries citing papers authored by Björn Rüter
This map shows the geographic impact of Björn Rüter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Rüter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Rüter more than expected).
Fields of papers citing papers by Björn Rüter
This network shows the impact of papers produced by Björn Rüter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Rüter. The network helps show where Björn Rüter may publish in the future.
Co-authorship network of co-authors of Björn Rüter
This figure shows the co-authorship network connecting the top 25 collaborators of Björn Rüter. A scholar is included among the top collaborators of Björn Rüter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Rüter. Björn Rüter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 7 | |
| 3 | 11 | |
| 4 | 16 | |
| 5 | 172 | |
| 6 | 403 | |
| 7 | A randomized, parallel-group, phase II study to evaluate the efficacy and safety of three doses of the integrin inhibitor cilengitide compared with docetaxel in patients with stage IV non-small cell lung cancer (NSCLC) after failure of first-line chemotherapy | 1 |
| 8 | 70 | |
| 9 | 1 | |
| 10 | 91 | |
| 11 | 19 | |
| 12 | 355 | |
| 13 | 1 | |
| 14 | 39 | |
| 15 | 50 | |
| 16 | 8 | |
| 17 | 1 | |
| 18 | 53 | |
| 19 | 7 | |
| 20 | 10 |
About Björn Rüter
Björn Rüter is a scholar working on Hematology, Genetics and Oncology, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Epigenetics and DNA Methylation (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Hematology (1.2k citations), Genetics (342 citations) and Emergency Medicine (104 citations). Björn Rüter has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Michael Lübbert, Pierre W. Wijermans, Rainer Claus, Arnold Ganser, Uwe Platzbecker, P. Wijermans, Ulrich Germing, Anne Hagemeijer, Jürgen Finke and Hartmut Bertz. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.